These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Canadian expert consensus: optimal treatment of neovascular age-related macular degeneration. Cruess AF; Berger A; Colleaux K; Greve M; Harvey P; Kertes PJ; Sheidow T; Tourville E; Williams G; Wong D Can J Ophthalmol; 2012 Jun; 47(3):227-35. PubMed ID: 22687297 [TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusion. Tan MH; McAllister IL; Gillies ME; Verma N; Banerjee G; Smithies LA; Wong WL; Wong TY Am J Ophthalmol; 2014 Jan; 157(1):237-247.e1. PubMed ID: 24112635 [TBL] [Abstract][Full Text] [Related]
4. Retinal vein thrombosis: pathogenesis and management. Rehak M; Wiedemann P J Thromb Haemost; 2010 Sep; 8(9):1886-94. PubMed ID: 20492457 [TBL] [Abstract][Full Text] [Related]
5. Reading speed improvements in retinal vein occlusion after ranibizumab treatment. Suñer IJ; Bressler NM; Varma R; Lee P; Dolan CM; Ward J; Colman S; Rubio RG JAMA Ophthalmol; 2013 Jul; 131(7):851-6. PubMed ID: 23699977 [TBL] [Abstract][Full Text] [Related]
6. Ischemic retinal vein occlusion: characterizing the more severe spectrum of retinal vein occlusion. Khayat M; Williams M; Lois N Surv Ophthalmol; 2018; 63(6):816-850. PubMed ID: 29705175 [TBL] [Abstract][Full Text] [Related]
7. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion. Singer MA; Bell DJ; Woods P; Pollard J; Boord T; Herro A; Porbandarwalla S Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480 [TBL] [Abstract][Full Text] [Related]
12. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema. Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239 [TBL] [Abstract][Full Text] [Related]
13. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial. Heier JS; Campochiaro PA; Yau L; Li Z; Saroj N; Rubio RG; Lai P Ophthalmology; 2012 Apr; 119(4):802-9. PubMed ID: 22301066 [TBL] [Abstract][Full Text] [Related]
14. Interventions for branch retinal vein occlusion: an evidence-based systematic review. McIntosh RL; Mohamed Q; Saw SM; Wong TY Ophthalmology; 2007 May; 114(5):835-54. PubMed ID: 17397923 [TBL] [Abstract][Full Text] [Related]
15. Current practice in the management of branch retinal vein occlusion in Japan: Survey results of retina specialists in Japan. Ogura Y; Kondo M; Kadonosono K; Shimura M; Kamei M; Tsujikawa A Jpn J Ophthalmol; 2019 Sep; 63(5):365-373. PubMed ID: 31428900 [TBL] [Abstract][Full Text] [Related]
16. Effects of intravitreal anti-vascular endothelial growth factor treatment on retinal vasculature in retinal vein occlusion as determined by ultra wide-field fluorescein angiography. Vance SK; Chang LK; Imamura Y; Freund KB Retin Cases Brief Rep; 2011; 5(4):343-7. PubMed ID: 25390431 [TBL] [Abstract][Full Text] [Related]